Bioniche Animal Health discovers, develops, manufactures and markets animal health products worldwide.
Headquartered in Canada, the Company was formed in 1979 to develop vaccines and other pharmaceutical-based products for the preventative health management of animal diseases. Bioniche Animal Health is now a division of Bioniche Life Sciences Inc., a public company (TSX: BNC and ASX: BNC).
Bioniche Animal Health markets a broad portfolio of products for companion animals, horses and the livestock industry, with a focus on four key areas:
21 December 2011
Equine Gastrafate® Distribution Agreement
Bioniche has entered into a distribution agreement with U.S.-based Mueller Medical International LLC for exclusive distribution in North America of... [read more]
21 December 2011
Celox™ Distribution Agreement
Bioniche has entered into a distribution agreement with UK-based MedTrade Products Limited for exclusive distribution in Canada of a number... [read more]
27 October 2011
NexHA™ Receives Canadian Regulatory Approval
NexHA™, a low molecular weight hyaluronate sodium product for horses, has received approval from Health Canada’s Veterinary Drugs Directorate, and... [read more]
view all recent news
 |
|||
|
|||
 |
|
|||
|
|||
|
|
|||
|
|||
|
2011 © Bioniche Animal Health a division of Bioniche Life Sciences. All rights reserved.
Google translate
